Bristol Myers Squibb
BREYANZI
Manufacturer:
Bristol Myers Squibb
Name:
BREYANZI
Category:
Q Code
HCPCS:
Q2054
NDC(s):
73153-0900-01,
Primary Type:
Cancer
Route of Administration:
Intravenous
About:
BREYANZI is a Cancer drug manufactured by Bristol Myers Squibb and administered via the Intravenous route of administration. The Q Code: Q2054 is aligned to the drug BREYANZI.